APA argues that CMS misrepresents APA practice guidelines by selectively quoting from them and ignoring factors that must be considered when choosing an antidepressant or antipsychotic.
There is a growing evidence base supporting the value of integrated care that includes clinical oversight that cannot be captured in the current coding structure.
Coordination between the VA’s prescription drug management plan and those run by states is critical to help monitor pain prescriptions written for veterans outside the Veterans Health Administration.
Multiple hurdles continue to hamper psychiatrists’ adoption of new health information technology and thus the receipt of Medicare financial incentives.
Johnson & Johnson was sued for failing to report data suggesting increased risks for stroke and diabetes associated with the antipsychotic Risperdal.
The final rule offers critical guidance on the status of intermediate-care benefits, transparency and disclosure of criteria by health plans, and provider reimbursement.
Judges and psychiatrists are putting their heads together to devise ways to temper justice with mental health care for defendants and prisoners.
Exchange health plans may not offer a full array of supportive services beyond inpatient and outpatient coverage, but a provision in the ACA allows states to amend their Medicaid plans to include them.
APA leaders say a final rule providing regulatory guidance for enforcement of the law is crucial and long overdue. The rule is expected to be issued later this year.
Read this week's Update
Sign Up for Psychiatric News Update newsletter